Talphera, Inc. (TLPH)

NCM – Real vaqt narxi. Valyuta: USD

1.03

-0.04 (-3.74%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

1.03

0.00 (0.00%)

Bozordan keyin: Jun 26, 2026, 4:10 PM EDT

13.05.2026

Talphera, Inc. (TLPH) Q1 2026 Earnings Call Transcript

13.05.2026

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

NEPHRO CRRT clinical study expected to be completed this year Cash and investments of $21.1 million at March 31, 2026 Conference call and webcast to be held on Wednesday, May 13, 2026 at 4:30 pm ET SAN MATEO, Calif., May 13, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced first quarter 2026 financial results and provided a corporate update.

07.05.2026

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026

SAN MATEO, Calif., May 7, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that it will release first quarter 2026 financial results after market close on Wednesday, May 13, 2026, then host a live webcast and conference call at 4:30 p.m.

25.03.2026

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026

SAN MATEO, Calif., March 25, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the acceptance of two abstracts for presentation at the 31st Annual International Conference on Advances in Critical Care Nephrology: AKI & CRRT 2026 to be held March 29-April 2, 2026 in San Diego.

24.03.2026

Talphera, Inc. (TLPH) Analyst/Investor Day Transcript

23.03.2026

Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Previously announced achievement of 50% enrollment of the NEPHRO CRRT clinical study in March 2026 and closed the associated financing tranche of $4.1 million All 12 clinical study sites now able to enroll patients to support an expected study completion in 2026 Cash and investments of $20.4 million at December 31, 2025 Virtual investor and analyst day with business updates to be held on Monday, March 23, 2026 at 11:00 am ET SAN MATEO, Calif., March 23, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced fourth quarter and full year 2025 financial results and provided a corporate update.

18.03.2026

Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026

SAN MATEO, Calif., March 18, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that it will host a virtual investor and analyst event on Monday, March 23, 2026 at 11:00 AM ET featuring Blaithin McMahon, PhD, MBBChr (Medical University of South Carolina) and Joao Teixeira, MD (University of New Mexico), principal investigators in Talphera's NEPHRO CRRT study evaluating Niyad for continuous renal replacement therapy (CRRT).

Videolar

No Data

There is no data to display

Reytinglar oshishi / pasayishi

Ticker	Tashkilot	Reyting o‘zgarishi	Maqsadli narx	Sana
TLPH	H.C. Wainwright	Buy	undefined >> $3	June 5th 2026

Press-relizlar

13.05.2026

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

25.03.2026

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026

23.03.2026

Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

18.03.2026

Talphera, Inc. (TLPH)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Talphera, Inc. (TLPH)

Talphera, Inc. (TLPH) Q1 2026 Earnings Call Transcript

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026

Talphera, Inc. (TLPH) Analyst/Investor Day Transcript

Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026

Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026

Talphera, Inc. (TLPH) Q1 2026 Earnings Call Transcript

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026

Talphera, Inc. (TLPH) Analyst/Investor Day Transcript

Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026

Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026

Search stocks

Talphera, Inc. (TLPH)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Talphera, Inc. (TLPH)

Talphera, Inc. (TLPH) Q1 2026 Earnings Call Transcript

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026

Talphera, Inc. (TLPH) Analyst/Investor Day Transcript

Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026

Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026

Talphera, Inc. (TLPH) Q1 2026 Earnings Call Transcript

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026

Talphera, Inc. (TLPH) Analyst/Investor Day Transcript

Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026

Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026